Replay available

STAAR Surgical Company (STAA) Q1 2026 Earnings Call

STAAR Surgical Company (NASDAQ: STAA) Q1 2026 earnings conference call, held 2026-05-13. Replay captured from the company's public earnings webcast.

Wed, May 13, 2026 at 5:30 PMendedReplay
STAAR Surgical Company (STAA) Q1 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Connie Johnson

Director of Investor Relations

Warren Faust

Interim Co-CEO, President, and Chief Operating Officer

Deborah Andrews

Interim Co-CEO and Chief Financial Officer

John Young

Analyst, Canaccord Genuity

Tom Stephan

Analyst, Stiefel

Simran Kaur

Analyst, Wells Fargo

Anthony Patron

Analyst, Mizuho Group

Ryan Zimmerman

Analyst, BTIG

David Saxon

Analyst, Needham & Co.

Mason Carrico

Analyst, Stevens

Adam Mader

Analyst, Piper Sandler

Replay transcript excerpt

Greetings, and welcome to the Star Surgical first quarter 2026 results call and webcast. During today's presentation, all parties will be in a listen-only mode. I would now like to turn the call over to Connie Johnson, Director of Investor Relations. Thank you, Operator. Good afternoon, and thank you for joining us. On the call today are Warren Faust, Interim Co-CEO, President, and Chief Operating Officer of Star Surgical. and Deborah Andrews, Interim Co-CEO and Chief Financial Officer of Star Surgical. Earlier today, we reported a first quarter 2026 results via press release and Form 8K. We posted our results release and shareholder letter to our investor website at investors.star.com. Today's call is scheduled for one hour and will include Q&A for publishing analysts. Webcast participants can also send questions for today's Q&A session to ir.star.com. Before we get started, I want to remind you that during today's call, we will be making forward-looking statements. Forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such forward-looking statements. I encourage you to read the disclosures in today's release as well as disclosures in our filings with the SEC. Except as required by law, STAR assumes no obligation to update these forward-looking statements to reflect future events or actual outcomes. In addition, during today's discussion, we will reference certain non-GAAP financial measures, including adjusted EBITDA and constant currency sales. Please refer to today's release for definitions and reconciliations of non-GAAP metrics. For brevity, unless otherwise specified, all comparisons on today's call will be on a year-over-year basis versus the relevant period. Fin...

More from Staar Surgical Company